Data / Form D filings / Pagari Life Science Corp.
Pagari Life Science Corp.: Form D filings
Pagari Life Science Corp., a pharmaceuticals company in Bethalta, IL, filed 4 Form D notices with the SEC between 2023 and 2026. The latest, on May 12, 2026, reports $97,494 sold of a $300,000 offering to 8 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 333 WEST BETHALTO DRIVE, Bethalta, IL, 62010
- Phone
- (314) 920-8321
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2022
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1993125
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| May 12, 2026 | New notice | $300,000 | $97,494 | $202,506 | 8 | Apr 28, 2026 | sec.gov |
| May 29, 2025 | New notice | $4,000,000 | $55,500 | $3,944,500 | 6 | May 23, 2025 | sec.gov |
| Apr 8, 2024 | New notice | $600,000 | $275,000 | $325,000 | 2 | Mar 26, 2024 | sec.gov |
| Oct 27, 2023 | New notice | $450,000 | $250,000 | $200,000 | 3 | Oct 13, 2023 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| David Feldker | Executive Officer, Director | |
| Stephen Peipert | Executive Officer, Director | |
| Marni Zenkewicz | Executive Officer | |
| James Wickenhauser | Executive Officer |
Every Form D from the week of May 11, 2026 · All recent filings in Illinois · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Pagari Life Science Corp. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.